Target intelligence / Profile preview

Insulin Secretion by Transplanted Beta Cells (N/A)

Target
N/A
Molecular classification
Cell Therapy, Endocrine Function, Cellular Process
01

Overview

Insulin secretion by transplanted beta cells refers to the restoration of endogenous insulin production in individuals with type 1 diabetes through the transplantation of functional beta cells. These cells, derived from either donor pancreases or stem cells, are intended to replace the function of destroyed native beta cells. The transplanted cells respond to glucose fluctuations by secreting insulin, thereby regulating blood glucose levels. Successful transplantation aims to improve glycemic control, reduce or eliminate the need for exogenous insulin, and prevent severe hypoglycemic events. However, challenges such as immune rejection, autoimmune recurrence, and cell survival post-transplantation remain significant considerations.

Other names
Transplanted islet functionBeta cell engraftmentIslet transplantationBeta-cell replacement therapy
02

Mechanism of action

Glucose-stimulated insulin secretion: Glucose metabolism in beta cells leads to ATP production, subsequent closure of KATP channels, membrane depolarization, calcium influx, and insulin granule exocytosis.

03

Biological functions

Glucose homeostasisInsulin productionInsulin secretionGlycemic control
04

Disease associations

Type 1 DiabetesInsulin deficiency
05

Safety considerations

Immunosuppression-related complications (infections, malignancy)Graft rejectionAutoimmune recurrenceHypoglycemiaThrombosis (portal vein)Islet cell apoptosis/ER stress
06

Interacting drugs

Immunosuppressants (e.g., Tacrolimus, Sirolimus)

2 more in the full profile.

07

Biomarkers

C-peptide levels (measure of endogenous insulin production)HbA1c (glycemic control)Insulin levelsAntibodies against islet cells (ICA), GAD65, IA-2 (monitoring autoimmunity)

Beyond the preview

Go deeper on Insulin Secretion by Transplanted Beta Cells (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin Secretion by Transplanted Beta Cells (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call